{"id":"https://openalex.org/W2556094889","doi":"https://doi.org/10.1182/blood.v120.21.299.299","title":"A Targeted Mutational Landscape of Angioimmunoblastic T-Cell Lymphoma: Association Between Advanced Age and Mutations in TET2 and DNMT3A","display_name":"A Targeted Mutational Landscape of Angioimmunoblastic T-Cell Lymphoma: Association Between Advanced Age and Mutations in TET2 and DNMT3A","publication_year":2012,"publication_date":"2012-11-16","ids":{"openalex":"https://openalex.org/W2556094889","doi":"https://doi.org/10.1182/blood.v120.21.299.299","mag":"2556094889"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v120.21.299.299","doi":"https://doi.org/10.1182/blood.v120.21.299.299","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v120.21.299.299","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048714300","display_name":"Oliver Weigert","orcid":"https://orcid.org/0000-0002-0987-7373","observed_orcids":["https://orcid.org/0000-0002-0987-7373"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Oliver Weigert","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002179064","display_name":"Nadja Kopp","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Nadja Kopp","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042880969","display_name":"Sudha Bolla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sudha Bolla","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019564077","display_name":"Oreofe Olukemi Odejide","orcid":"https://orcid.org/0000-0002-8117-7224","observed_orcids":["https://orcid.org/0000-0002-8117-7224"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Oreofe Odejide","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033683267","display_name":"Daniel T. Toscano","orcid":"https://orcid.org/0000-0002-1805-4416","observed_orcids":["https://orcid.org/0000-0002-1805-4416"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Dan Toscano","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088179815","display_name":"Matthew Alexander Lunning","orcid":"https://orcid.org/0000-0002-2761-7612","observed_orcids":["https://orcid.org/0000-0002-2761-7612"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew A Lunning","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071873190","display_name":"Julie Teruya\u2010Feldstein","orcid":"https://orcid.org/0000-0003-0033-445X","observed_orcids":["https://orcid.org/0000-0003-0033-445X"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie Teruya-Feldstein","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030353708","display_name":"Abner Louissaint","orcid":"https://orcid.org/0000-0001-6707-917X","observed_orcids":["https://orcid.org/0000-0001-6707-917X"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Abner Louissaint","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058975989","display_name":"Scott J. Rodig","orcid":"https://orcid.org/0000-0003-1761-9769","observed_orcids":["https://orcid.org/0000-0003-1761-9769"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott J. Rodig","raw_affiliation_strings":["Brigham and Women's Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069406522","display_name":"Steven Michael Horwitz","orcid":"https://orcid.org/0000-0002-6399-2006","observed_orcids":["https://orcid.org/0000-0002-6399-2006"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven M. Horwitz","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, NY, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, NY, USA,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026688095","display_name":"David M. Weinstock","orcid":"https://orcid.org/0000-0002-8724-3907","observed_orcids":["https://orcid.org/0000-0002-8724-3907"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Weinstock","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, USA,","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5002179064","https://openalex.org/A5019564077","https://openalex.org/A5030353708","https://openalex.org/A5033683267","https://openalex.org/A5042880969"],"corresponding_institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4210087915","https://openalex.org/I4210117453"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.36659383,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"120","issue":"21","first_page":"299","last_page":"299"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/angioimmunoblastic-t-cell-lymphoma","display_name":"angioimmunoblastic T-cell lymphoma","score":0.9929999709129333},{"id":"https://openalex.org/keywords/mutational-landscape","display_name":"mutational landscape","score":0.8980000019073486},{"id":"https://openalex.org/keywords/tet2","display_name":"TET2","score":0.8560000061988831},{"id":"https://openalex.org/keywords/dnmt3a","display_name":"DNMT3A","score":1.0},{"id":"https://openalex.org/keywords/old-age","display_name":"old age","score":0.5669999718666077},{"id":"https://openalex.org/keywords/single-nucleotide-variants","display_name":"single nucleotide variants","score":0.6380000114440918},{"id":"https://openalex.org/keywords/indels","display_name":"indels","score":0.8709999918937683},{"id":"https://openalex.org/keywords/somatic-mutations","display_name":"somatic mutations","score":0.5329999923706055},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.7039999961853027},{"id":"https://openalex.org/keywords/targeted-sequencing","display_name":"targeted sequencing","score":0.5210000276565552},{"id":"https://openalex.org/keywords/low-frequency-variants","display_name":"low-frequency variants","score":0.4950000047683716},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6320000290870667},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.3310000002384186},{"id":"https://openalex.org/keywords/prognostic-score","display_name":"prognostic score","score":0.367000013589859}],"concepts":[{"id":"https://openalex.org/C2776365654","wikidata":"https://www.wikidata.org/wiki/Q4763257","display_name":"Angioimmunoblastic T-cell lymphoma","level":4,"score":0.7826820611953735},{"id":"https://openalex.org/C76818968","wikidata":"https://www.wikidata.org/wiki/Q181940","display_name":"Sanger sequencing","level":4,"score":0.596733808517456},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5869282484054565},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4842471778392792},{"id":"https://openalex.org/C2777872185","wikidata":"https://www.wikidata.org/wiki/Q486090","display_name":"Anaplastic large-cell lymphoma","level":3,"score":0.4495491087436676},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4148469865322113},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.35561710596084595},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.30442583560943604},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.2738530933856964},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.271013468503952},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.23156434297561646},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.22416141629219055},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.20565181970596313},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.07988914847373962}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v120.21.299.299","doi":"https://doi.org/10.1182/blood.v120.21.299.299","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v120.21.299.299","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4408095645","https://openalex.org/W2041598067","https://openalex.org/W2979844721","https://openalex.org/W2984936271","https://openalex.org/W2581226163","https://openalex.org/W2268932527","https://openalex.org/W4319332911","https://openalex.org/W4309738946","https://openalex.org/W2073504536","https://openalex.org/W2752283479"],"abstract_inverted_index":{"Abstract":[0,1],"299":[2],"Angioimmunoblastic":[3],"T-cell":[4,11,39],"lymphoma":[5,12],"(AITL)":[6],"is":[7,54,644],"a":[8,16,78,147,191,318,324,350,368,590,614],"subtype":[9],"of":[10,19,38,43,62,68,73,96,105,114,123,126,136,151,160,164,174,187,198,224,273,337,353,371,425,448,462,593,607,617,627,641],"that":[13,83,120,429,465,652],"manifests":[14],"with":[15,52,141,245,304,310,349,409,416,451,460,474,486,497,510,523,613,621,633,646],"broad":[17],"array":[18],"neoplastic":[20],"and":[21,31,41,77,89,111,131,157,180,190,200,217,265,294,332,364,413,438,492,518,538,561,573],"paraneoplastic":[22],"manifestations,":[23],"including":[24,406,595],"generalized":[25],"lymphadenopathy,":[26],"hepatosplenomegaly,":[27],"systemic":[28],"symptoms,":[29],"rash":[30],"hypergammaglobulinemia.":[32],"AITL":[33,53,69,97,143,372,608],"accounts":[34],"for":[35,472,484,495,508,521],"approximately":[36],"20%":[37],"lymphomas":[40,46],"1\u20132%":[42],"all":[44,161,249,435],"non-Hodgkin":[45],"(NHL).":[47],"Median":[48,226,339,470,506],"survival":[49,341],"among":[50,228,342],"patients":[51,239,276,309,345,473,485,496,509,522],"less":[55],"than":[56],"3":[57,321,417,500],"years,":[58],"although":[59],"the":[60,106,112,134,210,229,307,343,381,385,421,423,439,600,605,650,653],"course":[61],"illness":[63],"varies":[64],"widely.":[65],"Histologic":[66],"examination":[67],"characteristically":[70],"demonstrates":[71],"proliferation":[72],"high":[74],"endothelial":[75],"venules":[76],"polymorphic":[79],"infiltrate,":[80],"malignant":[81,142],"cells":[82,379,437],"resemble":[84],"CD4+":[85],"follicular":[86],"helper":[87],"T-cells":[88],"occasional":[90],"EBV-positive":[91],"lymphoid":[92],"cells.":[93,117,144,662],"The":[94],"genetics":[95,606],"remain":[98],"almost":[99],"completely":[100],"undefined,":[101],"in":[102,172,209,219,367,402,445,457,546,568,599,631,638],"part":[103],"because":[104],"low":[107,137],"tumor":[108,199,214,436],"cell":[109,300],"fraction":[110],"abundance":[113],"non-malignant":[115],"bystander":[116],"We":[118],"reasoned":[119],"targeted":[121,148],"sequencing":[122,159,188,197],"selected":[124],"genes":[125,166,618],"interest":[127],"would":[128],"increase":[129],"coverage":[130],"thereby":[132],"enable":[133],"detection":[135],"frequency":[138],"variants":[139,178,586],"present":[140,433,444],"To":[145],"define":[146],"mutational":[149],"landscape":[150],"AITL,":[152],"we":[153,388],"performed":[154],"exon":[155],"capture":[156],"next-generation":[158],"coding":[162],"exons":[163],"197":[165],"known":[167],"to":[168],"be":[169],"recurrently":[170],"altered":[171],"cases":[173,204,231,244,408,415,450,464,578],"NHL.":[175],"Single":[176],"nucleotide":[177],"(SNVs)":[179],"insertions/deletions":[181],"were":[182,240,443,532,544,566,587],"confirmed":[183],"by":[184,195],"manual":[185],"review":[186],"reads":[189,221,427],"subset":[192],"was":[193,232,346,432,477,513],"validated":[194],"Sanger":[196],"germline":[201],"tissue.":[202],"Twenty-six":[203],"collected":[205],"from":[206,380],"three":[207],"sites":[208],"USA":[211],"had":[212,251,263,268,329,335],"adequate":[213,246],"specimens":[215],"available":[216],"resulted":[218],"high-quality":[220],"(median":[222],"depth":[223],"coverage\u223c300).":[225],"age":[227,471,507],"26":[230,344,386],"66.5":[233],"years":[234,479,483,494,515,520],"(range":[235,356,480,490,503,516,526],"30\u201389).":[236],"Twelve":[237],"(46%)":[238],"male.":[241],"Among":[242,306,420],"21":[243,250],"clinical":[247],"annotation,":[248],"advanced":[252,647],"stage":[253,256,259],"disease":[254,331],"(11":[255],"3,":[257],"10":[258],"4),":[260],"13":[261],"(62%)":[262],"B-symptoms":[264],"19":[266],"(90%)":[267],"an":[269],"ECOG":[270],"performance":[271],"score":[272],"0\u20132.":[274],"Ten":[275],"received":[277,281,287,291],"CHOP-like":[278],"regimens,":[279,285],"4":[280],"non-anthracycline":[282],"containing":[283],"chemotherapy":[284],"5":[286,333,397,407],"prednisone":[288],"monotherapy,":[289,293],"2":[290,399,410,414,441,498,577],"cyclosporine":[292],"one":[295,430,487,634],"patient":[296],"underwent":[297],"allogeneic":[298],"stem":[299,378,661],"transplantation":[301],"after":[302,312],"cytoreduction":[303],"alemtuzumab.":[305],"17":[308,403,449],"staging":[311],"first-line":[313],"treatment,":[314],"8":[315,395],"(47%)":[316],"achieved":[317,323],"complete":[319],"response,":[320,326],"(18%)":[322],"partial":[325],"1":[327],"(6%)":[328],"stable":[330],"(29%)":[334],"progression":[336],"disease.":[338],"overall":[340],"420":[347],"days":[348,355],"median":[351],"follow-up":[352],"426":[354],"21\u20133532).":[357],"Recent":[358],"studies":[359],"have":[360],"identified":[361,389,533,588],"both":[362],"TET2":[363,391,411,418,452,467,476,488,501],"DNMT3A":[365,512,525,628],"mutations":[366,392,412,442,453,456,468,502,531,543,565,581,637,654],"small":[369,615],"number":[370,592,616],"samples":[373],"as":[374,376],"well":[375],"hematopoietic":[377,660],"same":[382],"patients.":[383],"From":[384],"cases,":[387,405,612],"28":[390],"(13":[393],"frameshift,":[394],"nonsense,":[396],"missense,":[398],"splice":[400],"site)":[401],"(65.4%)":[404],"mutations.":[419,625],"latter,":[422],"fractions":[424],"mutant":[426],"suggested":[428],"mutation":[431,489],"within":[434,659],"other":[440],"subclones.":[446],"Six":[447],"also":[454],"harbored":[455,579],"DNMT3A,":[458],"compared":[459],"0":[461],"9":[463],"lacked":[466],"(p=0.06).":[469],"wild-type":[475,511],"56":[478],"30\u201383),":[481],"68":[482],"55\u201389),":[491],"77":[493],"or":[499,635],"59\u201384;":[504],"p<10\u22124).":[505],"64":[514],"30\u201384)":[517],"75.5":[519],"mutated":[524],"64\u201389;":[527],"p=0.03).":[528],"Known":[529],"gain-of-function":[530],"at":[534],"JAK3":[535],"V722I":[536],"(n=2)":[537],"IDH2":[539],"R172K":[540],"(n=1).":[541,563],"Frame-shift":[542],"recovered":[545,567],"ABCA7":[547],"(n=1),":[548,550,554,560,570],"ARID1B":[549],"CREBBP":[551],"(n=2),":[552,556,558,572],"GNAS":[553],"IKZF2":[555],"PRDM1":[557],"SMARCA2":[559],"TNFRSF14":[562],"Nonsense":[564],"ALPK2":[569],"CCND3":[571],"CHD8":[574],"(n=2).":[575],"Only":[576],"TP53":[580],"(M133R,":[582],"S261_splice).":[583],"Additional":[584],"missense":[585],"across":[589,611],"large":[591],"genes,":[594],"several":[596],"previously":[597,619],"described":[598],"COSMIC":[601],"database.":[602],"In":[603],"conclusion,":[604],"vary":[609],"broadly":[610],"associated":[620,645],"NHL":[622],"harboring":[623],"recurrent":[624],"Mutations":[626],"commonly":[629],"occur":[630],"combination":[632],"more":[636],"TET2.":[639],"Mutation":[640],"either":[642],"locus":[643],"age,":[648],"supporting":[649],"hypothesis":[651],"are":[655],"acquired":[656],"over":[657],"time":[658],"Disclosures:":[663],"Horwitz:":[664],"Seattle":[665],"Genetics:":[666],"Consultancy,":[667,671,675,698],"Research":[668,672,676,695,699],"Funding;":[669,673,677],"Allos:":[670],"Celgene:":[674],"Bristol-Myers":[678],"Squibb:":[679],"Consultancy;":[680,682,687,691],"Genzyme:":[681],"Kyowa":[683],"Hakko":[684],"Kirin":[685],"Pharma:":[686],"Johnson":[688],"&":[689],"Johnson:":[690],"Infinity":[692],"Pharmaceuticals,":[693],"Inc.:":[694],"Funding.":[696,700],"Weinstock:Novartis:":[697]},"counts_by_year":[],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2016-11-30T00:00:00"}